Celldex Therapeutics (CLDX) PT Raised to $72 at Wells Fargo
Tweet
Share
E-mailGet Alerts CLDX Hot Sheet
Price: $37.89 -0.92%
Rating Summary:
18 Buy, 3 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 9 | Down: 6 | New: 28
Rating Summary:
18 Buy, 3 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 9 | Down: 6 | New: 28
Join SI Premium – FREE
Wells Fargo analyst Derek Archila raised the price target on Celldex Therapeutics (NASDAQ: CLDX) to $72.00 (from $48.00) while maintaining a Overweight rating.
You May Also Be Interested In
- BofA Securities Upgrades Candel Therapeutics Inc. (CADL) to Buy
- Noah Holdings Ltd. (NOAH) PT Lowered to $9.70 at JPMorgan
- Jefferies Starts Oversea-Chinese Banking Corp Ltd (OCBC:SP) (OVCHF) at Hold
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
